BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hunt CM, Beste LA, Lowy E, Suzuki A, Moylan CA, Tillmann HL, Ioannou GN, Lim JK, Kelley MJ, Provenzale D. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration. World J Gastroenterol 2016; 22(19): 4732-4740 [PMID: 27217704 DOI: 10.3748/wjg.v22.i19.4732]
URL: https://www.wjgnet.com/1007-9327/full/v22/i19/4732.htm
Number Citing Articles
Patrik Garren, Marina Serper. Chronic Hepatitis B in US VeteransCurrent Hepatology Reports 2019; 18(3): 310 doi: 10.1007/s11901-019-00479-9
Mahnur Haider, Gianina Flocco, Rocio Lopez, William Carey. Retrospective observational study of temporal trends and outcomes of hepatitis B screening in patients receiving rituximabBMJ Open 2020; 10(12): e043672 doi: 10.1136/bmjopen-2020-043672
Urbano Sbarigia, Furaha Kariburyo, Janvi Sah, Jamie Colasurdo, Lin Xie, Eva G. Katz, Shirley Sylvester. Evaluating the Effect of Standard of Care Treatment on Burden of Chronic Hepatitis B: A Retrospective Analysis of the United States Veterans PopulationAdvances in Therapy 2020; 37(3): 1156 doi: 10.1007/s12325-020-01240-1
Jason T. Blackard, Kenneth E. Sherman. Hepatitis B virus (HBV) reactivation—The potential role of direct‐acting agents for hepatitis C virus (HCV)Reviews in Medical Virology 2018; 28(4) doi: 10.1002/rmv.1984
Cara D. Varley, Kevin L. Winthrop. Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections)Current Rheumatology Reports 2021; 23(9) doi: 10.1007/s11926-021-01037-3
Lok-Ka Lam, Thomas Sau Yan Chan, Yu-Yan Hwang, Lung-Yi Mak, Wai-Kay Seto, Yok-Lam Kwong, Man-Fung Yuen. Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapyVirology Journal 2023; 20(1) doi: 10.1186/s12985-023-02140-w
Ye Eun Kwak, Stacy M. Stein, Joseph K. Lim. Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital NetworkDigestive Diseases and Sciences 2018; 63(1): 61 doi: 10.1007/s10620-017-4850-1
Sirish Sanaka, Hans L Tillmann. Article Commentary: Hindsight is 20/20 – the Importance of Knowing! Know your Patients’ HBV StatusAntiviral Therapy 2018; 23(6): 471 doi: 10.3851/IMP3260